Shannon Breen Selected Research

Shannon Breen Research Topics

9	Neoplasms (Cancer) 11/2023 - 05/2012
2	Multiple Myeloma 01/2020 - 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Breast Neoplasms (Breast Cancer) 05/2018
1	Carcinoma (Carcinomatosis) 01/2017
1	Carcinogenesis 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 11/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2014
1	Body Weight (Weight, Body) 05/2012

3	AntigensIBA 11/2023 - 01/2017
3	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2017
2	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2014
1	Surface Antigens (Surface Antigen)IBA 11/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2018
1	Valine (L-Valine)FDA Link 11/2017
1	maleimideIBA 11/2017
1	DipeptidesIBA 11/2017
1	Alanine (L-Alanine)FDA Link 11/2017
1	Cytotoxins (Cytolysins)IBA 01/2017
1	MEDI0641IBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	Gefitinib (Iressa)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	CytokinesIBA 01/2016
1	Messenger RNA (mRNA)IBA 11/2014
1	Insulin-Like PeptidesIBA 11/2014
1	TOR Serine-Threonine KinasesIBA 11/2014
1	dusigitumabIBA 11/2014
1	Retinaldehyde (Retinal)IBA 05/2012
1	Bevacizumab (Avastin)FDA Link 05/2012
1	Angiogenesis InhibitorsIBA 05/2012
1	Angiopoietin-2IBA 05/2012
1	TIE-2 Receptor (Receptor, TIE 2)IBA 05/2012
1	Monoclonal AntibodiesIBA 05/2012
1	MEDI3617IBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 05/2012